Wikipedia -WSS

Wikipedia

author：knowledge 2025-10-01 22:08:28 - browse：6

Jakub Porzycki/NurPhoto via AP

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, everyone. Damian here with the fallout from Pfizer’s downbeat update, a new entrant in obesity research, and an orthogonal CRISPR business.

The need-to-know this morning

Apellis Pharmaceuticals said a European advisory committee is expected to recommend against the approval of Syfovre, its eye drug for a common form of blindness. The company plans to appeal the negative ruling.
Sage Therapeutics and Biogen announced the commercial launch of Zurzuvae, an oral treatment for women with postpartum depression.
Merck and Moderna reported three-year follow-up data on their mRNA-based immunotherapy for advanced melanoma. Phase 3 studies are underway.
The FDA accepted Amgen’s marketing application for tarlatamab, a bispecific antibody to treat advanced small cell lung cancer. The approval decision date is June 12, 2024.

Is it time to worry about Moderna?

Yesterday’s news that Pfizer is expecting to sell far fewer Covid-19 vaccines than Wall Street expected sent shares of Moderna down as much as 6% on fears that the company could be in for a painful revision of its own.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Biotech incubator Curie.Bio graduates its first startup

Wikipedia

WSS

Sanofi CEO defends move to abandon profit guidance, boost research

10 million people disenrolled from Medicaid over past six months

Medicare Advantage today, explained in one chart

UCSF medical school apologizes for unethical prisoner experiments

The Sacklers, horror, and ‘The Fall of the House of Usher’

FDA approves Recor Medical high blood pressure device

explore

Wikipedia

The need-to-know this morning

Is it time to worry about Moderna?

entertainment

Medical leaders decry Supreme Court decision on affirmative action

Victims of gun violence feel impacts long after bullet wound

Jerome Adams on the need for new antivirals for Covid

White House calls on federal agencies to crack down on AI abuses

How one medical school became remarkably diverse

Study: New antibiotic targets gonorrhea as well as last existing drug

Moonlake's readout produced a cash windfall. Risks remain

How digital therapeutics firms are pivoting after Pear's bankruptcy

Activists slam private health insurers over coverage restrictions

NIH director takes cautious approach to Biden drug pricing priority

hotspot

STAT Executive Editor Rick Berke on STAT's 8th birthday

The Sacklers, horror, and ‘The Fall of the House of Usher’

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

A clever new way to fix Medicaid and graduate medical education

How digital therapeutics firms are pivoting after Pear's bankruptcy

FDA clears AI tool for detecting skin cancer

focus

focus

Wikipedia

Wikipedia